Genistein treatment in prostate cancer significantly down-regulated miR-1260b and caused subsequent up-regulation of its targets sFRP1 and Smad4 by DNA demethylation and histone modifications, which caused a suppression of prostate cancer cells [59]. Here, SFRP1 is linked to prostate cancer.